Levosimendan and amrinone did not change coranary flow and heart rate significantly at any concentration (p>0.05). Both groups had worse contractility in reperfusion period. Levosimendan was a more potent inotropic agent in the reperfusion period because this group had higher +dx/dtmax (p=0.004) values. Contractility was also better in levosimendan but this was not statistically significant (p=0.359). In conclusion, levosimendan is a betten inotropic drug for ischaemic hearts than amrinone and this may be due to its calcium sensitizing properties in addition to the phosphodiesterase inhibiting activity.